Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
Junedh Amrute(Amgen (United States)), Kory J. Lavine(Washington University in St. Louis), Sally Yu Shi(Xalud Therapeutics (United States)), Farid F. Kadyrov(Washington University in St. Louis), Tracy Yamawaki(Washington University in St. Louis), Guoshai Feng(Washington University in St. Louis), Andrea Bredemeyer(Washington University in St. Louis), Vinay Penna(Washington University in St. Louis), Rafael Kramann(Brigham and Women's Hospital), Sikander Hayat(Universitätsklinikum Aachen), Chi-Ming Li(Icahn School of Medicine at Mount Sinai), Benjamin J. Kopecky(Washington University in St. Louis), Daniel Kreisel(Washington University in St. Louis), Yuriko Terada(Washington University in St. Louis), Brandon Ason(Amgen (United States)), Nathan O. Stitziel(Amgen (United States)), Andrew L. Koenig(Washington University in St. Louis), Angela Fu(Amgen (United States)), Pan Ma(Washington University in St. Louis), Steven Yang, Christoph Kuppe(RWTH Aachen University), Milena B. Furtado(Amgen (United States)), Gyu Seong Heo(Mallinckrodt (United States)), Cameran Jones(Washington University in St. Louis), Yongjian Liu(Washington University in St. Louis), Xin Luo(The University of Texas Southwestern Medical Center)
Cited by 14
Related Papers
Decoding myofibroblast origins in human kidney fibrosis
|Nature|2020|728
Tissue Resident CCR2− and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury
|Circulation Research|2019|717
Spatial multi-omic map of human myocardial infarction
|Nature|2022|692